, 2021 /PRNewswire/ -
InMed Pharmaceuticals Inc. ( InMed or the Company ) (Nasdaq: INM) (TSX: IN), a clinical-stage pharmaceutical company developing medications targeting diseases with high unmet medical need and leading the clinical development of cannabinol ( CBN ), today announced that it has closed the previously announced private placement.
Under the terms of the private placement, an aggregate of 1,050,000 units were purchased, each unit comprised of one common share and 0.66 of a warrant to purchase one common share, at a placement price of US$4.25 per unit. The warrants have an exercise price of US$4.85, are exercisable six months following issuance, and have a term of five and one half years following issuance. After the placement agent fees and estimated offering expenses payable by the Company, the Company expects to receive net proceeds of approximately US$4.0 million.
Desert Mountain Energy Provides Guidance on Estimated Helium Reserves on First Well
News provided by
Share this article
DESERT MOUNTAIN ENERGY CORP. (the Company ) (TSX.V: DME) (U.S. OTC: DMEHF) (Frankfurt: QM01) From the President of the Company.
Desert Mountain Energy Corp. (the Company ) (TSXV: DME) is pleased to announce guidance on helium reserves on its first well completed in 2020. The reserve estimate table is provided to help provide guidance on possible reservoir scenarios based on four point flow testing and correlated by Dr. Ed Coalson. The report is available on the DME website or click HERE. Currently there is no other known helium production from the perforated zone in the State 10-1 well within 100 miles. In addition, per the AZOGCC rules, only one well may be drilled and completed for any type of gas (including helium), per square mile in this area. Actual future production may, at some unknown time, provide directive to a possible increase of well density
/PRNewswire/ The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Sona Nanotech Inc..
/PRNewswire/ ManifestSeven Holdings Corporation (CSE: MSVN; OTCMKTS: MNFSF) ("M7" or the "Company"), California s first integrated omnichannel platform for.
Halo Collective Continues to Import to the United Kingdom, Now Offering Flower from Canada to UK Patients
News provided by
Share this article
All figures in USD unless stated otherwise
TORONTO, Feb. 16, 2021 /CNW/ - Halo Collective Inc. (
Halo or the
Company ) (NEO: HALO) (OTCQX: HCANF formerly AGEEF) (Germany: A9KN) is pleased to announce further imports of Cannabis-Based Products for Medicinal use (
CBPMs ) to the United Kingdom via the Company s wholly-owned subsidiary Canmart Ltd (
Canmart ). While Canmart had previously imported tincture originating in the European Union (
EU ), its importation program has now expanded to flower products from Canada. Following the Company s acquisition of Canmart in November 2020, Halo is executing on its plan to import an assortment of CBPMs to qualified UK patients in search of high-quality medical cannabis.